Tailoring antiplatelet therapy duration after PFO closure: insights from the PROLONG registry

19 February 2026 (08:00 - 18:30)

Organised by:

Sign in to view the resources

Sign in for access options

About the speaker

Doctor Carlo Gaspardone

University Vita-Salute San Raffaele, Milan (Italy)

5 More presentations in this session

Presentation thumbnail

Effectiveness of intraprocedural guidance modalities on PFO closure outcomes: insights from the PROLONG registry

Doctor C. Gaspardone (Milan, IT)

Abstract Slides

Presentation thumbnail

Long term outcomes of patent foramen ovale closure in elderly patients

Doctor D. D'Atri (Mainz, DE)

Abstract Slides

Presentation thumbnail

Sex differences in clinical characteristics and outcomes after transcatheter patent foramen ovale closure

Doctor C. Gaspardone (Milan, IT)

Abstract Slides

Presentation thumbnail

Atrial arrhythmias after PFO closure: a randomized, controlled, investigator-inititiated, multicentre study (ASPARAGUS) - preliminary results.

Assistant Professor A. Pietrasik (Warsaw, PL)

Abstract Slides

Presentation thumbnail

Clinical and hemodynamic outcomes of transcatheter iatrogenic atrial shunting in patients with heart failure: a systematic review and meta-analysis

Doctor N. Pyrpyris (Athens, GR)

Abstract Slides

Access the full session

Session thumbnail

The inter-atrial septum: a therapeutic target

The Event

Event poster

EAPCI Summit 2026

19 February - 20 February 2026

You may be interested in

Congress Presentation

A reversible cause of heart failure?

Congress Presentation

Navigating anatomical barriers: successful amplatzer closure of a high-risk patent foramen ovale after failed noblestitch

Congress Presentation

Reintervention for intraprosthetic residual shunt following patent foramen ovale

ESC 365 is supported by

novartis

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources